Apogee Therapeutics Inc
NASDAQ:APGE
Income Statement
Earnings Waterfall
Apogee Therapeutics Inc
Income Statement
Apogee Therapeutics Inc
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(56)
|
(93)
|
(119)
|
(144)
|
(178)
|
(217)
|
(242)
|
(271)
|
(283)
|
|
| Selling, General & Administrative |
(16)
|
(25)
|
(30)
|
(36)
|
(42)
|
(49)
|
(56)
|
(63)
|
(66)
|
|
| Research & Development |
(39)
|
(68)
|
(89)
|
(108)
|
(137)
|
(168)
|
(185)
|
(208)
|
(216)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
|
| Operating Income |
(56)
N/A
|
(93)
-67%
|
(119)
-27%
|
(144)
-21%
|
(178)
-24%
|
(217)
-22%
|
(242)
-11%
|
(271)
-12%
|
(283)
-5%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
4
|
9
|
15
|
25
|
31
|
35
|
36
|
33
|
30
|
|
| Pre-Tax Income |
(52)
N/A
|
(84)
-61%
|
(104)
-23%
|
(118)
-14%
|
(147)
-24%
|
(182)
-24%
|
(205)
-13%
|
(237)
-16%
|
(253)
-7%
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(52)
|
(84)
|
(104)
|
(118)
|
(147)
|
(182)
|
(205)
|
(238)
|
(254)
|
|
| Net Income (Common) |
(52)
N/A
|
(84)
-61%
|
(104)
-23%
|
(118)
-14%
|
(147)
-24%
|
(182)
-24%
|
(205)
-13%
|
(238)
-16%
|
(254)
-7%
|
|
| EPS (Diluted) |
-1.09
N/A
|
-1.74
-60%
|
-1.83
-5%
|
-2.09
-14%
|
-2.58
-23%
|
-3.3
-28%
|
-3.52
-7%
|
-4.06
-15%
|
-4.31
-6%
|
|